We would love to hear your thoughts about our site and services, please take our survey here.
Hi Profit, it could be massive. Cadran currently is used by a handful of Trusts, if the NHS decide the new technology must be used widely then Cadran itself must be bought by most/all Trusts. Mobile images that are up to clinical standards and viable for diagnostic use will be a huge aid to clinicians. As Cadran is CE marked that may also open the door to European sales? Unaware of the income impact but would have thought it could be huge given the size of the market. So if successful the current sp looks a steal, in two years time we may wish we had not ignored this golden egg imo, dyor.
Shocking shareholder neglect of late. It is almost as if FDBK do not care whether the company is successful or not, the protracted silence in light if a depressed/declining sp is deafening. This really is turning into farcical neglect by the BOD, quite shameful!
Morning folks, frustrations run high when shareholders feel aggrieved and to be fair the Company can only blame themselves for refusing to dialogue with their owners. I hope you get a reasonable reply soon Hors, if not then perhaps it is time to tap into larger shareholders who surely must be in the loop? Not a happy place to be invested at present, shame FDBK feel the need to alienate their supporters by neglect.
Yes El, even if the Review is planned to come out with the Results at least let us know that! At the moment I fear there is internal strife behind the delay, which would be catastrophic. Such silence breeds conspiracy...better to be open and upfront with investors.
Like many have said FDBK is NOT a large complex conglomerate....it is a tiny tech wannabe. I accept the CEO wants to be thorough in his review but surely 20+ weeks is ample time to understand where the Company is, where it can go and how it will get there! If nothing else then at least TO ought to get his communication links working, continued market silence does nobody any favours.
So let us hope this weeks brings some news or at the very least a date for when the Review and Strategy will be announced. Shareholders have been taken for granted long enough by the BOD, time to be honest!
That’s a very late notification and no notice of a director trade or tr1. Interesting to go all in at such a premium, would have expected a staggered buy. Will the sp respond tomorrow? Clearly mms trying to shake some stock from elders today.
Will there be an announcement in the next day or so?
Morning Hors, all you say is true...yet the sp falls and there are some chunky sells! It really is time for the BOD to get active and let the market know what is happening, are they living in the real world at all? This is a commercial business not some cosy scientific club for arrogant backslappers. Hence my exasperation.
Ahead, have we turned the corner? Will volume stay high as buyers come back in on the strength of positive news? Will FDBK let the moment pass by, not letting the market know what their plans are and the sp just drifts again? Hopefully these, still, bargain basement prices will attract lths, with Cadran being actively promoted and TexRAD’s wide geographic research footprint, potential FDA application etc anything sub-2p is a steal imo.
Awaiting TO review in detail. After 18weeks+ this should be very in depth and hopefully will provide a clear path to commercial success, then the market may sit up and take notice. Let’s see where we are in 7 days time, aimho dyor.
DNA of non alignment ....brilliant Bo, where did you drag that one from? Yes even I have dipped my toes in to buy again recently, there does seem to be reasonable expectation of a positive announcement and current sp must be bargain basement if this is to ever do well.
I think others are right though, we do need to know when TO is likely to complete his review and announce his findings. Then a trading update with roadmap for the future needs to be visible to assure markets that there is actually a vision for progress.
Finally as El said recently regular updates should be the norm to establish a relationship with the market/investors that has hitherto been abandoned. Then we might see a progressive sp based upon confidence that the BOD knows what it is doing and where it is going, that confidence has been missing for far too long! So if you do have confidence now might be the time to stock up aimho of course, dyor.
Yes El, there would be no problem with market sensitive info....simply an update on trading. I am invested in another
AIM stock which regularly keeps investors informed, it isn’t rocket science but does wonders for confidence....and FDBK seriously needs for the market to gain some confidence in the direction it is going.
Amazing lack of contact El, 18 weeks is surely long enough to give an indication of when information is likely? There does seem to be ignorance on the market effect of silence, hope I am wrong but market awareness has always been a problem for FDBK.
Despite chunky buys, and I suspect many of the reds are also buys, today the sp falls again. If there really is any good news then it’s time imo for the CEO to start his charm offensive with the market. AIM abhors a vacuum of information so let’s start with ECR 2019 and continue the information outflow on a regular basis until investors get the message that there is a stock worthy of their attention. Cadran alone has to be worth more in the market than FDBK is currently worth so why are the BOD not banging on doors and shouting their collective heads off, ridiculous JV at present for the Company!
Hi Bo that is what I really don’t understand mate. If TexRAD is so internationally acclaimed and reviewed then selling into mainstream clinical use with all the revenue that brings should be a doddle but we still await orders. I accept getting medical approval is not a quick process but the review caravan has been on the road for a few years now, perhaps we are now at the beginning of large scale acceptance? If so the next 12 months should be interesting.
Evening all....the sp continues its downward spiral and despite this having been the case for several months not a word from our custodial BOD!!! Shocking situation where the Board preside over a collapse in the value of the Company with no specific comment. It’s almost as if they have no regard to their responsibility to their shareholders, in which case do they need to be replaced? Are the present BOD ever going to realise the commercial value of the property they have, there has been no evidence in the past 2 years since CE Mark
Haha Bo, that’s far too much work! My guess given the progress visible to date:
9.30 ish, some turn up for work
10.00 coffee break after effort of finding desk
11.00 game of hunt the Boss (see if any have turned up)
12-2.00 lunch to prepare for hard pm shift
2.15 turn on laptop
2.30 no enquiries begging for TexRAD so time to relax
3.00 coffee break
4.00 no Bosses arrived so time to wind down ahead of hectic drive home
4.30 lights out end of another fruitful day in Bourne, fingers crossed no enquiries tomorrow.
Least shareholders expectations will not have been unduly raised and the world beating diagnostic tool that is TexRAD will still be safely hidden from useful application!
May seem a little harsh with only the two coffee breaks but is it not reflective of the visible clinical sales progress to date? Think FDBK need a new CEO quickly.
Any other thoughts, Bob...
Agree Bo, couldn’t bring myself to sell at this sp even if I wanted to! Reckon news or not in the next 3 months will be pivotal going forward. Herald, TC, Cranston, SS etc did not buy in and hold for nothing, they know a lot more than us and my guess is they believe some very good news is not far away. A waiting game for sure, but then with FDBK when wasn’t it?